Table 3

Growth-inhibitory effects of antifolates against AA8 and PyrR100 cells grown under different folic acid concentrations

AntifolateTargetPolyglutamylationIC50
AA8 (2.3 μM FA)AA8 (100 nM FA)PyrR100 (2.3 μM FA)PyrR100 (5 nM FA)
nM
MTXDHFR+23  ± 13.4  ± 0.779  ± 244.9  ± 1.6
EDXDHFR+1.7  ± 0.70.7  ± 0.212  ± 31.3  ± 0.8
PT523DHFR1.8  ± 0.20.5  ± 0.220  ± 21.0  ± 0.5
TMQDHFR10  ± 40.4  ± 0.3401  ± 392.9  ± 1.5
PyrDHFR214  ± 4310  ± 6150,0005875  ± 1305
AG377DHFR/TS27  ± 142.5  ± 1.5820  ± 10016  ± 6
ZD1694TS+17  ± 33.2  ± 0.821  ± 81.5  ± 1.0
GW1843TS+253  ± 1133  ± 14141  ± 512.5  ± 2.2
LY231514/MTATS+43  ± 96.9  ± 0.9109  ± 403.8  ± 2.5
ZD9331TS1665  ± 39058  ± 35900  ± 18510  ± 8
AG337TS20,220  ± 67501030  ± 56062,280  ± 14,8202385  ± 1315
DDATHFGARFT+62  ± 366.2  ± 1.11600  ± 10653.0  ± 1.9
AG2032GARFT+81  ± 165.3  ± 2.296  ± 335.5  ± 2.0
AG2034GARFT+28  ± 113.2  ± 0.8402  ± 2222.6  ± 1.2
  • The 50% growth-inhibitory concentration (IC50 in nM) was determined after 72-h drug exposure. Results are the mean ± S.D. of three to six separate experiments.